Pulsed cavitational therapy using high-frequency ultrasound for the treatment of deep vein thrombosis in an <i>in vitro</i> model of human blood clot. Goudot, G, Mirault, T, Arnal, B, Boisson-Vidal, C, Le Bonniec, B, Gaussem, P, Galloula, A, Tanter, M, Messas, E, & Pernot, M Physics in Medicine & Biology, 62(24):9282–9294, November, 2017. 5 citations (Crossref) [2023-04-11]
Pulsed cavitational therapy using high-frequency ultrasound for the treatment of deep vein thrombosis in an <i>in vitro</i> model of human blood clot [link]Paper  doi  abstract   bibtex   
Post-thrombotic syndrome, a frequent complication of deep venous thrombosis, can be reduced with early vein recanalization. Pulsed cavitational therapy (PCT) using ultrasound is a recent non-invasive approach. We propose to test the efficacy and safety of high-frequency focused PCT for drug-free thrombolysis (thrombotripsy) in a realistic in vitro model of venous thrombosis.
@article{goudot_pulsed_2017,
	title = {Pulsed cavitational therapy using high-frequency ultrasound for the treatment of deep vein thrombosis in an \textit{in vitro} model of human blood clot},
	volume = {62},
	issn = {1361-6560},
	url = {https://iopscience.iop.org/article/10.1088/1361-6560/aa9506},
	doi = {10.1088/1361-6560/aa9506},
	abstract = {Post-thrombotic syndrome, a frequent complication of deep venous thrombosis, can be reduced with early vein recanalization. Pulsed cavitational therapy (PCT) using ultrasound is a recent non-invasive approach. We propose to test the efficacy and safety of high-frequency focused PCT for drug-free thrombolysis (thrombotripsy) in a realistic in vitro model of venous thrombosis.},
	language = {en},
	number = {24},
	urldate = {2022-02-22},
	journal = {Physics in Medicine \& Biology},
	author = {Goudot, G and Mirault, T and Arnal, B and Boisson-Vidal, C and Le Bonniec, B and Gaussem, P and Galloula, A and Tanter, M and Messas, E and Pernot, M},
	month = nov,
	year = {2017},
	note = {5 citations (Crossref) [2023-04-11]},
	pages = {9282--9294},
}

Downloads: 0